Increasing evidence has suggested that FOXM1 is elevated in many tumors, such as intrahepatic cholangiocarcinoma, oesophageal adenocarcinoma, gastric cancer, cervical cancer, and HCC [18–24]. The gene discussed is FOXM1; the disease is intrahepatic cholangiocarcinoma.